Skip to content
FDA drug shortage status

Is Clindamycin Phosphate Injection (Cleocin Phosphate) in shortage?

Yes. Clindamycin Phosphate Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

In shortageFDA status
20packages listed
5unavailable

Why it’s in shortage

  • Discontinuation of the manufacture of the drug
  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)
    Baxter HealthcareIn shortageAvailableUpdated Nov 18, 2026

    Maker contact: 888-229-0001

  • Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)
    Baxter HealthcareIn shortageAvailableUpdated Nov 18, 2026

    Maker contact: 888-229-0001

  • Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)
    Baxter HealthcareIn shortageAvailableUpdated Nov 18, 2026

    Maker contact: 888-229-0001

  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)
    Sandoz Inc.In shortageAvailableUpdated Nov 9, 2026

    Maker contact: 800-525-8747

  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)
    Sandoz Inc.In shortageAvailableUpdated Nov 9, 2026

    Maker contact: 800-525-8747

  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)
    Sandoz Inc.In shortageAvailableUpdated Nov 9, 2026

    Maker contact: 800-525-8747

  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)
    Sandoz Inc.In shortageAvailableUpdated Nov 9, 2026

    Civica Label

    Maker contact: 800-525-8747

  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)
    Sandoz Inc.In shortageAvailableUpdated Nov 9, 2026

    Civica Label

    Maker contact: 800-525-8747

  • Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)
    Pfizer Inc.In shortageUnavailableUpdated Nov 6, 2026

    Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay More from the maker

    Maker contact: 800-533-4535

  • Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)
    Pfizer Inc.In shortageUnavailableUpdated Nov 6, 2026

    Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay More from the maker

    Maker contact: 800-533-4535

  • Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)
    Pfizer Inc.In shortageUnavailableUpdated Nov 6, 2026

    Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay More from the maker

    Maker contact: 800-533-4535

  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)
    Sagent PharmaceuticalsIn shortageLimited AvailabilityUpdated Nov 6, 2026

    Selling through remaining short-dated inventory (Dec 2026).

    Maker contact: 866-625-1618

  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)
    Sagent PharmaceuticalsIn shortageUnavailableUpdated Nov 6, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 866-625-1618

  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)
    Sagent PharmaceuticalsIn shortageLimited AvailabilityUpdated Nov 6, 2026

    Selling through remaining short-dated inventory (Dec 2026).

    Maker contact: 866-625-1618

  • Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)
    Baxter HealthcareIn shortageAvailableUpdated Nov 3, 2026

    Maker contact: 888-229-0001

  • Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)
    Baxter HealthcareIn shortageUnavailableUpdated Nov 3, 2026

    Estimated recovery: January 2027

    Maker contact: 888-229-0001

  • Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)
    Baxter HealthcareIn shortageLimited AvailabilityUpdated Nov 3, 2026

    Estimated recovery: November 2026

    Maker contact: 888-229-0001

  • Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02)
    Pfizer Inc.Being discontinuedUpdated Jun 1, 2026Discontinued Jun 1, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 844-646-4398

  • Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04)
    Pfizer Inc.Being discontinuedUpdated Jun 1, 2026Discontinued Jun 1, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 844-646-4398

  • Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06)
    Pfizer Inc.Being discontinuedUpdated Jun 1, 2026Discontinued Jun 1, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 844-646-4398

Clindamycin Phosphate Injection shortage questions

Is Clindamycin Phosphate Injection (Cleocin Phosphate) in shortage?

Yes. Clindamycin Phosphate Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

Why is there a Clindamycin Phosphate Injection shortage?

FDA records the reason as: Discontinuation of the manufacture of the drug; Other.

What should I do if I can’t get Clindamycin Phosphate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.